急性肺血栓栓塞症的诊治

doi:10.3969/j.issn.1004-583X.2016.04.001

临床荟萃 ›› 2016, Vol. 31 ›› Issue (4): 349-351.doi: 10.3969/j.issn.1004-583X.2016.04.001

• 专题 • 下一篇

急性肺血栓栓塞症的诊治

杨媛华, 周荣荣

首都医科大学附属北京朝阳医院呼吸与危重症医学科,北京呼吸疾病研究所,北京 100020

收稿日期:2016-01-15 出版日期:2016-04-05 发布日期:2016-04-18
通讯作者: 杨媛华,Email:yyh1031@sina.com
作者简介:杨媛华，医学博士，主任医师，副教授，硕士研究生导师。中华医学会呼吸病学分会肺栓塞学组委员。长期从事呼吸系统疾病的临床、教学和科研工作，主要研究方向为肺栓塞和肺动脉高压的诊断与治疗。在相关领域参与完成包括国家科技攻关、科技支撑计划等多项课题的研究。
基金资助:
国家“十二五”科技支撑计划课题(2011BAI11B17,2012BA105B00)

Progression of diagnosis and treatment in acute pulmonary thromboembolism

Yang Yuanhua, Zhou Rongrong

Department of Respirology and Critical Medicne, Beijing Chaoyang Hospital, Capital Medical University Beijing Institute of Respiratory Medicine, Beijing 100020,China

Received:2016-01-15 Online:2016-04-05 Published:2016-04-18
Contact: Yang Yuanhua,Email: yyh1031@sina.com

摘要/Abstract

摘要： 近年来,在肺血栓栓塞症(PTE)的诊断与治疗方面新的循证医学证据不断出现,在VTE的诊治方面出现了一些新的理念,如急性PTE的危险分层的进一步细化,提出高危患者的处理意见,血浆D-二聚体更加适合于除外急性PTE的诊断,中危患者治疗的精准把握,低危患者的早期出院或家庭治疗等,本文就上述问题,结合最新肺栓塞诊治指南中的指导意见进行进一步解读,以使临床医生追踪PTE诊治领域的最新学术前沿,为PTE患者制定最佳的诊治方案。

关键词: 肺栓塞, 血栓栓塞, 诊断, 治疗, D-二聚体

Abstract: In recent years, as the new evidence-based medical evidence on diagnosis and treatment of pulmonary thromboembolism(PTE) appear constantly, some new concepts have been pointed out, such as the clinical classification of the severity of acute PTE becomes more elaborated, recommendation for management of high-risk patients, plasma D-dimer is more suitable to rule out acute PTE, treatment of moderate-risk patients, early discharge or home treatment of low-risk patient and so on. In order to make clinicians get the newest trends in diagnosis and treatment of PTE and finally formulate the most effective therapeutic plan for patients with PTE, we unscramble the new guidelines on the diagnosis and management of acute PTE according to above mentioned problems.

Key words: pulmonary thromboembolism, thromboembolism, diagnosis, treatment, D-dimer

中图分类号:

R563.5

杨媛华, 周荣荣. 急性肺血栓栓塞症的诊治[J]. 临床荟萃, 2016, 31(4): 349-351.

Yang Yuanhua, Zhou Rongrong. Progression of diagnosis and treatment in acute pulmonary thromboembolism[J]. Clinical Focus, 2016, 31(4): 349-351.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.04.001

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I4/349

参考文献

[1] Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014,35(43): 3033-69, 3069a-3069k.
[2] Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med,2006,354(22): 2317-2327.
[3] 杨媛华. 对基础医院肺血栓栓塞症处理策略的思考[J].中华医学杂志, 2015,95(30): 2419-2420.
[4] Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)[J]. Eur Heart J,2008,29(18): 2276-2315.
[5] Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism[J]. Am J Respir Crit Care Med, 2005, 172(8): 1041-1046.
[6] Fancher TL, White RH, Kravitz RL. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review[J]. BMJ,2004,329(7470): 821.
[7] Righini M, van Es J, Den EPL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study[J].JAMA, 2014,311(11): 1117-1124.
[8] Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism[J]. N Engl J Med,2014,370(15): 1402-1411.
[9] Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis[J]. JAMA,2014,311(23): 2414-2421.
[10] Kline JA, Steuerwald MT, Marchick MR, et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure[J]. Chest, 2009, 136(5): 1202-1210.
[11] Wang C, Zhai Z, Yang Y, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial[J]. Chest, 2010, 137(2): 254-262.
[12] Zhang Z, Zhai ZG, Liang LR, et al. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis[J]. Thromb Res,2014,133(3): 357-363.
[13] Bagla S, Smirniotopoulos JB, van Breda A, et al. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism[J]. J Vasc Interv Radiol, 2015,26(7): 1001-1006.
[14] 常生杰, 孙炳华, 卢乐平, 等. 选择性肺动脉内溶栓治疗肺栓塞20例临床体会[J]. 临床荟萃,2013,28(1): 69-70.
[15] Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J].N Engl J Med, 2012, 366(14): 1287-1297.
[16] Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism[J].N Engl J Med, 2013,369(9): 799-808.

急性肺血栓栓塞症的诊治

Progression of diagnosis and treatment in acute pulmonary thromboembolism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王奕涵, 秦旭雁, 韩宣泽, 王樱洁, 高菲菲, 陈春红, 张岭楠, 张芳. 利伐沙班用于HASBLED评分≥3分的高龄非瓣膜性心房颤动患者的有效性和安全性[J]. 临床荟萃, 2024, 39(2): 121-124.
[2]	刘蕾, 李明武, 万荣. 肺结核合并肺栓塞患者实验室指标的诊断价值[J]. 临床荟萃, 2024, 39(2): 134-139.
[3]	金鑫, 吴金玲, 尹丽丽. 持续性植物状态促醒机制及治疗研究进展[J]. 临床荟萃, 2024, 39(2): 172-176.
[4]	王琦, 陈宏. 维生素D在支气管哮喘和慢性阻塞性肺疾病治疗中的应用进展[J]. 临床荟萃, 2024, 39(1): 88-91.
[5]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[6]	邹子良, 余海, 王迪, 褚泰运, 李驹, 钱宝堂. 冠状动脉慢性完全闭塞病变介入治疗研究现状[J]. 临床荟萃, 2024, 39(1): 80-83.
[7]	游琪琪, 霍丽娟. 原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征的诊治进展[J]. 临床荟萃, 2024, 39(1): 84-87.
[8]	赵浩天, 李丽. 肺超声在心脏急重症疾病合并肺水肿中应用的研究进展[J]. 临床荟萃, 2023, 38(9): 832-837.
[9]	王鑫, 张展, 刘铎, 谢萍. 铁缺乏与肺动脉高压相关性的研究进展[J]. 临床荟萃, 2023, 38(9): 838-844.
[10]	陈聪水, 李园, 陈淑芳. 重视儿童胆源性胰腺炎的中西医诊治(附1例分析)[J]. 临床荟萃, 2023, 38(8): 726-730.
[11]	武锐锋, 刘宇宏. PDZ结合激酶/T淋巴细胞因子激活的杀伤细胞源性蛋白激酶的作用机制及其在肿瘤治疗中的潜在价值[J]. 临床荟萃, 2023, 38(8): 763-768.
[12]	侯有玲, 李奕, 关红玉, 罗红霞. 目标导向液体治疗在脑肿瘤切除术中应用效果的meta分析[J]. 临床荟萃, 2023, 38(8): 686-693.
[13]	王玥, 陈辉, 岑奕, 张哲, 张欣, 李宗锡, 陈珍珍, 贾彤彤, 章美玲. 超声引导下侧入路颈脊神经后支三氧联合注射松解治疗颈脊神经后支源性慢性颈肩痛[J]. 临床荟萃, 2023, 38(8): 714-718.
[14]	张会, 丁东瑞, 金天然. 新型冠状病毒SARS-CoV-2的相关研究——过去与未来[J]. 临床荟萃, 2023, 38(7): 638-646.
[15]	郭文惠, 雷皓月, 潘友卓, 张琦. 质膜膜泡关联蛋白的生物学功能研究进展[J]. 临床荟萃, 2023, 38(7): 647-653.